1[1]Mcelroy SL.Clozapine in the treatment of psychotic mood disorders,schizoaffective disorder and schizophrenina.J Clin Psychiatry,1991,52:41
2[2]Tollefson GD,Sanger TM,Beasley CM,et al.Double-blind,controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanzing schizophrenia.Biol Psychiatry,1998,43:803
3Karaginais JI, Dawa IC, Thakur A, et al. Rapid tranquilization with olanzapine in acute psychosis : a case series[ J ]. J Clin Psychiatry,2001,62(Suppl 2) : 12-16.
4Shapiro DA, Renoch S, Arrington E, et al. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology[ J ]. Neuropsychopharmacology, 2003,28 ( 8 ):1 400.
5Kane JM, Carson WH, Saha AR, et al. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder [ J ]. J Clin Psychiatry, 2002,63(9) :763.
6Potkin SG, Saha AR, Kujawa MJ, et al. Aripipazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder [ J ]. Arch Gen Psychiatry, 2003,60(7) :681.
7Kern RS, Cornblatt B, Carson WH, et al. An open - label comparison of the neurocognitive effects of aripiprazole vs olanzapine in patients with stable psychosis [ J ]. Schizophr Res, 2001,49(suppl 1 - 2) :s234.
8Van Vliet BJ, Mos J, Vander Heijden JAM, et al. DU 127090:a highly potent, atypical dopamine receptor ligand- a putative potent full spectrum antipsychotic with low EPS potential[J]. Eur Neuropsychopharmacol, 2000, 10(suppl 3):s293.
9Hesselink MB, Van Vliet BJ, Ronken E, et al. DU 127090:a novel partial dopamine agonist with antipsychotic activity.High potency but low efficacy at dopamine D2 receptors [ J ].Schizophrenia Research, 2003, 60( 1 ): 108.
10De Vries MH, Vdo de Haes J, Long SK, et al. DU127090: a highly potent, atypical dopamine receptor ligand: pilot study of dopamine D2 receptor occupancy after multiple oral administration of DU 127090 to healthy male volunteers, using 11C - rac lopride by means of positron emission tomography [J]. Eur Neuropsychopharmacol, 2000, 10(suppl 3): s294.
